|
| 34136741 | Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer. | JCO Precis Oncol | 2021 |
| 32367460 | Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors. | Breast Cancer Res Treat | 2020 |
| 32816855 | Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression. | Cancer Res | 2020 |
| 30528798 | Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. | Eur J Cancer | 2019 |
| 29180605 | Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer. | Clin Cancer Res | 2018 |
| 29358169 | CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion. | Cancer Res | 2018 |
| 27771841 | Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer. | Breast Cancer Res Treat | 2017 |
| 28687903 | Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer. | Breast Cancer Res Treat | 2017 |
| 28679775 | Detection of Activating Estrogen Receptor Gene (<i>ESR1</i>) Mutations in Single Circulating Tumor Cells. | Clin Cancer Res | 2017 |
| 26944919 | Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity. | Mol Cancer Ther | 2016 |
| 28178640 | A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone. | Oncologist | 2016 |
| 27706044 | Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer. | Int J Mol Sci | 2016 |
| 26870807 | Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells. | EBioMedicine | 2015 |
| 26573830 | Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer. | Breast Cancer Res Treat | 2015 |
| 26264468 | The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study. | Breast Cancer Res Treat | 2015 |
| 24886365 | AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models. | J Exp Clin Cancer Res | 2014 |
| 25489582 | CTC enumeration and characterization: moving toward personalized medicine. | Ann Transl Med | 2014 |
| 23259914 | A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17. | J Proteome Res | 2013 |
| 24294976 | EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells. | J Exp Clin Cancer Res | 2013 |
| 24102046 | Presence of anaplastic lymphoma kinase in inflammatory breast cancer. | Springerplus | 2013 |
| 23647160 | Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer. | J Proteome Res | 2013 |
| 23784380 | Inflammatory breast cancer (IBC): clues for targeted therapies. | Breast Cancer Res Treat | 2013 |
| 22217916 | MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment. | Phys Med Biol | 2012 |
| 20960462 | PKA knockdown enhances cell killing in response to radiation and androgen deprivation. | Int J Cancer | 2011 |
| 21098923 | MR-guided focused ultrasound: enhancement of intratumoral uptake of [³H]-docetaxel in vivo. | Phys Med Biol | 2010 |
| 18196567 | Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo. | Prostate | 2008 |
| 17637390 | Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo. | Int J Radiat Oncol Biol Phys | 2007 |
| 16015611 | Antisense Bcl-2 sensitizes prostate cancer cells to radiation. | Prostate | 2005 |
| 14751501 | Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination. | Int J Radiat Oncol Biol Phys | 2004 |
| 15176048 | Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation. | Prostate | 2004 |
| 12196529 | Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression. | J Biol Chem | 2002 |
| 9579874 | Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia. | Eur J Haematol | 1998 |
| 9677375 | Cleavage of the cytoplasmic domain of the integrin beta3 subunit during endothelial cell apoptosis. | J Biol Chem | 1998 |
| 9583681 | Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. | Oncogene | 1998 |
| 9395203 | Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. | Carcinogenesis | 1997 |
| 9157977 | Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. | Cancer Res | 1997 |
| 9398618 | Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. | Biochem Biophys Res Commun | 1997 |
| 9031108 | The biologic function of PML and its role in acute promyelocytic leukemia. | Leuk Lymphoma | 1996 |
| 7759992 | PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. | J Exp Med | 1995 |
| 7780148 | The PML gene encodes a phosphoprotein associated with the nuclear matrix. | Blood | 1995 |
| 7935403 | PML, a growth suppressor disrupted in acute promyelocytic leukemia. | Mol Cell Biol | 1994 |
| 8018923 | Regulation of the expression of annexin VIII in acute promyelocytic leukemia. | Blood | 1994 |